JOSEPH M PATTI Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for JOSEPH M PATTI.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of JOSEPH M PATTI. JOSEPH M PATTI is a CEO in Aviragen Therapeutics, Inc. ($NABI) and a Director in Armata Pharmaceuticals, Inc. ($APHB) and a Chief Scientific Officer in INHIBITEX, INC. ($INHX).
Address: 1165 SANCTUARY PARKWAY SUITE 400 ALPHARETTA 30004 GA
Companies in which JOSEPH M PATTI is an Insider
Armata Pharmaceuticals, Inc.
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of JOSEPH M PATTI: Director
Holdings: 0 shares
Current Value: $0
Latest Transaction: Dec 09 2020
$APHB Market Capitalization: $5.61M
$APHB Previous Close: $0.54
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
INHIBITEX, INC.
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of JOSEPH M PATTI: Chief Scientific Officer
Holdings: 0 shares
Latest Transaction: Feb 22 2005
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Vaxart, Inc.
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of JOSEPH M PATTI: CEO
Holdings: 126,128 shares
Current Value: $143,786
Latest Transaction: Apr 05 2017
$VXRT Market Capitalization: $43.28M
$VXRT Previous Close: $1.14
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Latest Insider Trading Transactions of JOSEPH M PATTI
Sentiment: All, APHB, INHX, VXRT
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Dec 09 2020 | APHB | Armata Pharmaceuti ... | PATTI JOSEPH M | Director | Option Exercise | A | 3.15 | 23,000 | 72,450 | 23,000 | |
| May 24 2019 | APHB | Armata Pharmaceuti ... | PATTI JOSEPH M | Director | Option Exercise | A | 3.15 | 27,383 | 86,256 | 27,383 | |
| Apr 05 2017 | AVIR | Aviragen Therapeut ... | PATTI JOSEPH M | CEO | Option Exercise | A | 0.66 | 650,000 | 426,400 | 2,113,304 | |
| Aug 12 2016 | NABI | Aviragen Therapeut ... | PATTI JOSEPH M | CEO | Option Exercise | A | 1.30 | 380,000 | 494,000 | 1,478,929 | |
| Sep 28 2015 | NABI | Aviragen Therapeut ... | PATTI JOSEPH M | CEO | Buy | P | 1.85 | 2,500 | 4,625 | 126,128 | 123.6 K to 126.1 K (+2.02 %) |
| Sep 28 2015 | NABI | Aviragen Therapeut ... | PATTI JOSEPH M | CEO | Buy | P | 1.89 | 2,500 | 4,713 | 123,628 | 121.1 K to 123.6 K (+2.06 %) |
| Aug 13 2015 | NABI | Aviragen Therapeut ... | PATTI JOSEPH M | CEO | Option Exercise | A | 2.49 | 250,000 | 622,500 | 250,000 |